Literature DB >> 16371628

Safety of long-acting beta-agonists--an urgent need to clear the air.

Fernando D Martinez1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16371628     DOI： 10.1056/NEJMp058299

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.

Authors:  Aaron Deykin; Michael E Wechsler; Homer A Boushey; Vernon M Chinchilli; Susan J Kunselman; Timothy J Craig; Emily DiMango; John V Fahy; Monica Kraft; Frank Leone; Stephen C Lazarus; Robert F Lemanske; Richard J Martin; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Stanley J Szefler; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2006-09-14       Impact factor: 21.405

Review 2.  Management of asthma in children.

Authors:  J Townshend; S Hails; M McKean
Journal:  BMJ       Date:  2007-08-04

Review 3.  Long-acting beta2-agonists in asthma: not so SMART?

Authors:  Graeme P Currie; Daniel K C Lee; Brian J Lipworth
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Impact of race on asthma treatment failures in the asthma clinical research network.

Authors:  Michael E Wechsler; Mario Castro; Erik Lehman; Vernon M Chinchilli; E Rand Sutherland; Loren Denlinger; Stephen C Lazarus; Stephen P Peters; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

5.  Pharmacogenetics of asthma controller treatment.

Authors:  E B Mougey; C Chen; K G Tantisira; K V Blake; S P Peters; R A Wise; S T Weiss; J J Lima
Journal:  Pharmacogenomics J       Date:  2012-02-28       Impact factor: 3.550

6.  β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis.

Authors:  Sergio E Chiarella; Saul Soberanes; Daniela Urich; Luisa Morales-Nebreda; Recep Nigdelioglu; David Green; James B Young; Angel Gonzalez; Carmen Rosario; Alexander V Misharin; Andrew J Ghio; Richard G Wunderink; Helen K Donnelly; Kathryn A Radigan; Harris Perlman; Navdeep S Chandel; G R Scott Budinger; Gökhan M Mutlu
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 7.  Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.

Authors:  Paul L McCormack; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Asthma: clinical expression and molecular mechanisms.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

9.  Managing childhood asthma: challenge of preventing exacerbations.

Authors:  Fernando D Martinez
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

10.  Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.

Authors:  Robert W Dal Negro; Luis Borderias; Qiaoyi Zhang; Tao Fan; Vasilisa Sazonov; Magda Guilera; Stephanie D Taylor
Journal:  BMC Pulm Med       Date:  2009-03-30       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.